Innovative bio-pharmaceutical company.
| Year | Client | Period | Income | Expenses | Doc |
|---|---|---|---|---|---|
| 2013 | REATA PHARMACEUTICALS |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Termination (No Activity) |
— | — | |
| 2013 | REATA PHARMACEUTICALS |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report (No Activity) |
— | — | |
| 2012 | REATA PHARMACEUTICALS |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report (No Activity) |
— | — | |
| 2012 | REATA PHARMACEUTICALS |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | $65,000 | |
| 2012 | REATA PHARMACEUTICALS |
3rd Quarter (July 1 - Sep 30) Registration |
— | — |
| Client | Filings | Total Income |
|---|---|---|
| REATA PHARMACEUTICALS | 5 | — |
| Name | Disclosed Prior Position |
|---|---|
| MICHAEL EGING |